Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/INNATE-PHARMA-35620/news/Innate-Pharma-SA-Announces-Update-on-Avdoralimab-Phase-2-Force-Trial-in-COVID-19-Patients-With-Sever-35797657/?utm_source=whatsapp&utm_medium=social&utm_campaign=share